Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2013

01-04-2013

Calculating the Risk Benefit Equation for Aggressive Treatment of Non-convulsive Status Epilepticus

Authors: Matthew Ferguson, Matt T. Bianchi, Raoul Sutter, Eric S. Rosenthal, Sydney S. Cash, Peter W. Kaplan, M. Brandon Westover

Published in: Neurocritical Care | Issue 2/2013

Login to get access

Abstract

Objective

To address the question: does non-convulsive status epilepticus warrant the same aggressive treatment as convulsive status epilepticus?

Methods

We used a decision model to evaluate the risks and benefits of treating non-convulsive status epilepticus with intravenous anesthetics and ICU-level aggressive care. We investigated how the decision to use aggressive versus non-aggressive management for non-convulsive status epilepticus impacts expected patient outcome for four etiologies: absence epilepsy, discontinued antiepileptic drugs, intraparenchymal hemorrhage, and hypoxic ischemic encephalopathy. Each etiology was defined by distinct values for five key parameters: baseline mortality rate of the inciting etiology; efficacy of non-aggressive treatment in gaining control of seizures; the relative contribution of seizures to overall mortality; the degree of excess disability expected in the case of delayed seizure control; and the mortality risk of aggressive treatment.

Results

Non-aggressive treatment was favored for etiologies with low morbidity and mortality such as absence epilepsy and discontinued antiepileptic drugs. The risk of aggressive treatment was only warranted in etiologies where there was significant risk of seizure-induced neurologic damage. In the case of post-anoxic status epilepticus, expected outcomes were poor regardless of the treatment chosen. The favored strategy in each case was determined by strong interactions of all five model parameters.

Conclusions

Determination of the optimal management approach to non-convulsive status epilepticus is complex and is ultimately determined by the inciting etiology.
Appendix
Available only for authorised users
Literature
1.
Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 1999;16(4):341–52. discussion 353.PubMedCrossRef
2.
Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol. 2005;22(2):79–91.PubMedCrossRef
3.
Young GB, Jordan KG. Do nonconvulsive seizures damage the brain?–Yes. Arch Neurol. 1998;55(1):117.PubMedCrossRef
4.
5.
Kaplan PW. No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: “the cure may be worse than the disease”). Neurophysiol Clin. 2000;30(6):377–82.PubMedCrossRef
6.
Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus. Eur J Neurol. 2006;13(5):445–50.PubMedCrossRef
7.
Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology. 2003;61(8):1066–73.PubMedCrossRef
8.
Rossetti AO, Logroscino G, Liaudet L, et al. Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology. 2007;69(3):255–60.PubMedCrossRef
9.
Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39(8):2304–9.PubMedCrossRef
10.
Rossetti AO, Logroscino G, Milligan TA, et al. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561–6.PubMedCrossRef
11.
Young BG, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring an investigation of variables associated with mortality. Neurology. 1996;47(1):83–9.PubMedCrossRef
12.
Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698–702.PubMedCrossRef
13.
Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35(1):27–34.PubMedCrossRef
14.
Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12):1344–9.PubMedCrossRef
15.
Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia. 2009;50(6):1566–71.PubMedCrossRef
16.
Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology. 2007;69(9):886–93.PubMedCrossRef
17.
Alvarez V, Januel J-M, Burnand B, Rossetti AO. Role of comorbidities in outcome prediction after status epilepticus. Epilepsia. 2012;53(5):e89–92.PubMedCrossRef
18.
Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia. 2005;46(Suppl 9):73–9.PubMedCrossRef
19.
Andermann F, Robb JP. Absence status. A reappraisal following review of thirty-eight patients. Epilepsia. 1972;13(1):177–87.PubMedCrossRef
20.
Agathonikou A, Panayiotopoulos CP, Giannakodimos S, Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia. 1998;39(12):1265–76.PubMedCrossRef
21.
Claassen J, Jetté N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69(13):1356–65.PubMedCrossRef
22.
Wijdicks EFM, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67(2):203–10.PubMedCrossRef
23.
Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251–6.PubMedCrossRef
24.
Oddo M, Rossetti AO. Predicting neurological outcome after cardiac arrest. Curr Opin Crit Care. 2011;17(3):254–9.PubMedCrossRef
25.
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891–7.PubMedCrossRef
26.
Kosty J, Macyszyn L, Lai K, et al. Relating quality of life to Glasgow outcome scale health states. J Neurotrauma. 2012;29(7):1322–7.PubMedCrossRef
27.
Nichol AD, Higgins AM, Gabbe BJ, et al. Measuring functional and quality of life outcomes following major head injury: common scales and checklists. Injury. 2011;42(3):281–7.PubMedCrossRef
28.
Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003;34(7):1710–6.PubMedCrossRef
29.
Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol. 2011;68(5):573–9.PubMedCrossRef
30.
Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med. 1996;156(16):1829–36.PubMedCrossRef
31.
Shirasaka Y. Lack of neuronal damage in atypical absence status epilepticus. Epilepsia. 2002;43(12):1498–501.PubMedCrossRef
32.
Meldrum BS. Concept of activity-induced cell death in epilepsy: historical and contemporary perspectives. Prog Brain Res. 2002;135:3–11.PubMedCrossRef
33.
Guerrini R, Aicardi J, Arzimanoglou A. Aicardi’s epilepsy in children. 3rd ed. Philadelphia: Lippincott Williams; 2004.
34.
Gökyiğit A, Calişkan A. Diffuse spike-wave status of 9-year duration without behavioral change or intellectual decline. Epilepsia. 1995;36(2):210–3.PubMedCrossRef
35.
36.
Drislane FW, Lopez MR, Blum AS, Schomer DL. Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol. 2008;25(4):181–6.PubMedCrossRef
37.
Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.PubMedCrossRef
38.
DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39(8):833–40.PubMedCrossRef
39.
Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37(6):2051–6.PubMedCrossRef
40.
Delanty N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure. 2001;10(2):116–9.PubMed
41.
Vignatelli L, Rinaldi R, Baldin E, et al. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol. 2008;255(2):197–204.PubMedCrossRef
42.
DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40(2):164–9.PubMedCrossRef
43.
Waterhouse EJ, Garnett LK, Towne AR, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia. 1999;40(6):752–8.PubMedCrossRef
44.
Cooper AD, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol. 2009;66(12):1505–9.PubMedCrossRef
45.
Waterhouse EJ, Vaughan JK, Barnes TY, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res. 1998;29(3):175–83.PubMedCrossRef
46.
Vespa PM, O’Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60(9):1441–6.PubMedCrossRef
47.
Dennis LJ, Claassen J, Hirsch LJ, et al. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1136–43. discussion 1144.PubMedCrossRef
48.
Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg. 1999;91(5):750–60.PubMedCrossRef
49.
Vespa P, Prins M, Ronne-Engstrom E, et al. Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study. J Neurosurg. 1998;89(6):971–82.PubMedCrossRef
50.
DeGiorgio CM, Heck CN, Rabinowicz AL, et al. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology. 1999;52(4):746–9.PubMedCrossRef
51.
Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35(12):2830–6.PubMedCrossRef
52.
Vespa PM, McArthur DL, Xu Y, et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurology. 2010;75(9):792–8.PubMedCrossRef
53.
Foreman B, Hirsch LJ. Epilepsy emergencies: diagnosis and management. Neurol Clin. 2012;30(1):11–41, vii.
54.
Jordan KG, Hirsch LJ. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia. 2006;47(Suppl 1):41–5.PubMedCrossRef
55.
Young GB, Claassen J. Nonconvulsive status epilepticus and brain damage: further evidence, more questions. Neurology. 2010;75(9):760–1.PubMedCrossRef
56.
Claassen J, Lokin JK, Fitzsimmons B-FM, Mendelsohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58(1):139–42.PubMedCrossRef
57.
Grundmann H, Bärwolff S, Tami A, et al. How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med. 2005;33(5):946–51.PubMedCrossRef
58.
Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753–62.PubMedCrossRef
59.
Becker KJ, Baxter AB, Cohen WA, et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56(6):766–72.PubMedCrossRef
60.
Ali NA, O’Brien JM Jr, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261–8.PubMedCrossRef
61.
Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874–82.PubMedCrossRef
62.
Cheung AM, Tansey CM, Tomlinson G, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2006;174(5):538–44.PubMedCrossRef
63.
Angus DC, Musthafa AA, Clermont G, et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(6):1389–94.PubMed
64.
Jackson JC, Hart RP, Gordon SM, et al. Six-month neuropsychological outcome of medical intensive care unit patients. Crit Care Med. 2003;31(4):1226–34.PubMedCrossRef
65.
De Jonghe B, Sharshar T, Lefaucheur J-P, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859–67.PubMedCrossRef
66.
Forster AJ, Kyeremanteng K, Hooper J, Shojania KG, van Walraven C. The impact of adverse events in the intensive care unit on hospital mortality and length of stay. BMC Health Serv Res. 2008;8:259.PubMedCrossRef
67.
Garrouste-Orgeas M, Timsit JF, Vesin A, et al. Selected medical errors in the intensive care unit results of the IATROREF study: parts I and II. Am J Respir Crit Care Med. 2010;181(2):134–42.PubMedCrossRef
68.
69.
Bayliff CD, Schwartz ML, Hardy BG. Pharmacokinetics of high-dose pentobarbital in severe head trauma. Clin Pharmacol Ther. 1985;38(4):457–61.PubMedCrossRef
70.
Cordato DJ, Mather LE, Gross AS, Herkes GK. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology. 1999;91(6):1693–702.PubMedCrossRef
71.
Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia. 2007;48(Suppl 8):52–5.PubMedCrossRef
72.
Kress HG, Segmüller R. Intravenous anesthetics and human neutrophil granulocyte motility in vitro. Anaesthesist. 1987;36(7):356–61.PubMed
73.
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146–53.PubMedCrossRef
74.
Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792–8.PubMedCrossRef
75.
Naidech AM, Bendok BR, Tamul P, et al. Medical complications drive length of stay after brain hemorrhage: a cohort study. Neurocrit Care. 2009;10(1):11–9.PubMedCrossRef
76.
77.
78.
Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol. 2010;67(3):301–7.
Metadata
Title
Calculating the Risk Benefit Equation for Aggressive Treatment of Non-convulsive Status Epilepticus
Authors
Matthew Ferguson
Matt T. Bianchi
Raoul Sutter
Eric S. Rosenthal
Sydney S. Cash
Peter W. Kaplan
M. Brandon Westover
Publication date
01-04-2013
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 2/2013
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-012-9785-y

Other articles of this Issue 2/2013

Neurocritical Care 2/2013 Go to the issue

Original Article

Platelet Dysfunction is an Early Marker for Traumatic Brain Injury-Induced Coagulopathy

Letter to the Editor

Authors’ Reply: Confounding by Indication in Retrospective Studies of Intracerebral Hemorrhage: Antiepileptic Treatment and Mortality

Original Article

Mild Prolonged Hypothermia for Large Intracerebral Hemorrhage

Practical Pearl

Cardiomyopathy with Inverted Tako-Tsubo Pattern in the Setting of Subarachnoid Hemorrhage: A Series of Four Cases

OriginalPaper

Blood Transfusion is an Important Predictor of Hospital Mortality Among Patients with Aneurysmal Subarachnoid Hemorrhage

Practical Pearl

Intracranial Supraclinoid ICA Dissection Causing Cerebral Infarction and Subsequent Subarachnoid Hemorrhage